Key insights
- Craig-Hallum initiated coverage of Health In Tech (HIT) with a Buy rating and a $4 price target, implying significant upside. The firm cites HIT's AI-powered platform targeting the large U.S. group health market and its rapid revenue growth. While the company missed EPS expectations in Q4 2025, the analyst highlights the potential for expansion and the growing self-funded health plan market. This positive analyst coverage could provide a short-term boost to the stock.
Investing.com - Craig-Hallum initiated coverage on Health In Tech Inc. (NASDAQ:HIT) with a Buy rating and a price target of $4.00, according to a research note released Monday. The stock currently trades at $1.41, suggesting potential upside of nearly 184% to the target, with the company commanding a market capitalization of $98.34 million.
The firm highlighted the company’s AI-powered platform, the Enhanced Do-it-Yourself Benefit System (eDIYBS), which targets the $1.6 trillion U.S. group health market. The platform enables sign-ups in minutes versus days and offers instant quotes, customization and single-click access to ancillary coverage including critical illness, accident, dental, vision, term life and GAP coverage.
Health In Tech currently supports more than 23,000 billable enrolled employees, representing a 23% year-over-year increase but just 0.02% market share. The company reported 71% revenue growth year-over-year in fiscal year 2025, reaching $33.33 million in revenue for the last twelve months. According to InvestingPro data, the company is profitable over the last twelve months with a gross profit margin of 62.82%, though it trades at a high P/E ratio of 67. InvestingPro offers 11 additional exclusive tips for HIT, along with comprehensive Pro Research Reports covering this and 1,400+ other US equities.
Recent growth has been driven by a 40% year-over-year increase in third-party brokers and higher fees per enrolled employee. The U.S. group health market is expected to reach 75% penetration of self-funded plans by 2030, with more than 1 million licensed insurance brokers operating in the country.
Craig-Hallum analyst George Sutton noted the company operates an ecosystem of solutions serving the small employer market and has plans for expansion starting early this year.
In other recent news, Health In Tech, Inc. reported its fourth-quarter 2025 earnings, highlighting significant revenue growth despite missing earnings per share (EPS) expectations. The company achieved a quarterly revenue of $7.5 million, marking a 53% increase compared to the same period last year. However, the EPS recorded a loss of $0.01, falling short of the anticipated $0.01 and resulting in a negative surprise of 200%. Additionally, Health In Tech completed a private investment in public equity financing, raising approximately $7.0 million in gross proceeds. This financing involved the sale of 5,600,000 shares of common stock at $1.25 per share to institutional and accredited investors. Craig-Hallum Capital Group LLC acted as the sole placement agent for this transaction. These developments reflect recent activities surrounding Health In Tech, providing insight into its financial and strategic maneuvers.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.